EBSWORTH DAVID R — SEC Form 4 filings
SEC reporting owner CIK 1207107. 9 Form 4 filings on record with FilingPulse; latest filed 2025-10-08.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-04-30 to 2025-10-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 3 legs across 3 filings — 95,360 shares, $381,001 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 1,904 shares, $25,026 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 20.
- Largest priced transaction: purchase of 39,360 shares @ $4.80 ($188,881) in Verona Pharma plc, filed 2024-11-07.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Verona Pharma plc (VRNA) | Director | 9 | 3 legs · 95,360 sh · $381,001 | 1 leg · 1,904 sh · $25,026 | 20 |
Form 4 filings — EBSWORTH DAVID R
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-10-08 | 4 | Verona Pharma plc (VRNA) | Disposition to issuer (D): 880,499 · Option exercise (M): 72,000 · Disposition to issuer (D): 72,000 · Disposition to issuer (D): 617,600 · Option exercise (M): 72,000 (derivative) | EDGAR |
| 2025-08-05 | 4 | Verona Pharma plc (VRNA) | Option exercise (M): 24,000 @ $0 · Sale (S): 1,904 @ $13.14 · Option exercise (M): 24,000 (derivative) @ $0 | EDGAR |
| 2025-05-05 | 4 | Verona Pharma plc (VRNA) | Option exercise (M): 140,000 @ $1.93 · Option exercise (M): 140,000 (derivative) @ $0 | EDGAR |
| 2025-04-29 | 4 | Verona Pharma plc (VRNA) | Grant/award (A): 96,000 (derivative) @ $0 | EDGAR |
| 2025-02-28 | 4 | Verona Pharma plc (VRNA) | Option exercise (M): 64,000 @ $0.78 · Option exercise (M): 200,000 @ $0.50 · Option exercise (M): 96,000 @ $2.67 · Option exercise (M): 100,000 @ $1.93 · Gift (G): 64,000 @ $0 · Option exercise (M): 64,000 (derivative) @ $0 · +3 more | EDGAR |
| 2024-11-18 | 4 | Verona Pharma plc (VRNA) | Purchase (P): 20,000 @ $4.44 | EDGAR |
| 2024-11-07 | 4 | Verona Pharma plc (VRNA) | Purchase (P): 39,360 @ $4.80 | EDGAR |
| 2024-08-14 | 4 | Verona Pharma plc (VRNA) | Purchase (P): 36,000 @ $2.87 | EDGAR |
| 2024-04-30 | 4 | Verona Pharma plc (VRNA) | Grant/award (A): 240,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1207107 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →